Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 197

1.

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.

Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, Nishikawa M, Shimakami T, Shirasaki T, Sakai Y, Yamashita T, Takamura T, Tanaka T, Kaneko S.

Oncotarget. 2017 Feb 13. doi: 10.18632/oncotarget.15304. [Epub ahead of print]

2.

Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice.

Fukuta K, Shirakami Y, Maruta A, Obara K, Iritani S, Nakamura N, Kochi T, Kubota M, Sakai H, Tanaka T, Shimizu M.

Int J Mol Sci. 2017 Feb 15;18(2). pii: E413. doi: 10.3390/ijms18020413.

3.

Crystallographic structure of recombinant Lactococcus lactis prolidase to support proposed structure-function relationships.

Kgosisejo O, Chen JA, Grochulski P, Tanaka T.

Biochim Biophys Acta. 2017 Feb 4;1865(5):473-480. doi: 10.1016/j.bbapap.2017.02.004. [Epub ahead of print]

PMID:
28179139
4.

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis.

Tanaka T, Oyama T, Sugie S, Shimizu M.

Int J Mol Sci. 2016 Oct 28;17(11). pii: E1806.

5.

Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse.

Nolte T, Brander-Weber P, Dangler C, Deschl U, Elwell MR, Greaves P, Hailey R, Leach MW, Pandiri AR, Rogers A, Shackelford CC, Spencer A, Tanaka T, Ward JM.

J Toxicol Pathol. 2016;29(1 Suppl):1S-125S. doi: 10.1293/tox.29.1S. Epub 2016 Feb 13. Review.

6.

Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR Mice.

Tanaka T, Kochi T, Shirakami Y, Mori T, Kurata A, Watanabe N, Moriwaki H, Shimizu M.

Cancers (Basel). 2016 Feb 20;8(2). pii: E25. doi: 10.3390/cancers8020025.

7.

Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.

Miyazaki T, Shirakami Y, Kubota M, Ideta T, Kochi T, Sakai H, Tanaka T, Moriwaki H, Shimizu M.

Oncotarget. 2016 Mar 1;7(9):10448-58. doi: 10.18632/oncotarget.7249.

8.

Aldehyde dehydrogenase 1A1 in stem cells and cancer.

Tomita H, Tanaka K, Tanaka T, Hara A.

Oncotarget. 2016 Mar 8;7(10):11018-32. doi: 10.18632/oncotarget.6920. Review.

9.

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.

Shibata Y, Hara T, Nagano J, Nakamura N, Ohno T, Ninomiya S, Ito H, Tanaka T, Saito K, Seishima M, Shimizu M, Moriwaki H, Tsurumi H.

PLoS One. 2016 Jan 4;11(1):e0146279. doi: 10.1371/journal.pone.0146279. eCollection 2016 Jan 4.

10.

Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis.

Shirakami Y, Shimizu M, Kubota M, Ohno T, Kochi T, Nakamura N, Sumi T, Tanaka T, Moriwaki H, Seishima M.

Eur J Cancer Prev. 2016 May;25(3):206-15. doi: 10.1097/CEJ.0000000000000172.

PMID:
26258810
11.

Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.

Nakamura N, Hara T, Shimizu M, Mabuchi R, Nagano J, Ohno T, Kochi T, Kubota M, Shirakami Y, Goto N, Ito H, Saito K, Tanaka T, Moriwaki H, Tsurumi H.

Int J Hematol. 2015 Sep;102(3):327-34. doi: 10.1007/s12185-015-1835-8. Epub 2015 Aug 5.

PMID:
26243621
12.

ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.

Tanaka K, Tomita H, Hisamatsu K, Nakashima T, Hatano Y, Sasaki Y, Osada S, Tanaka T, Miyazaki T, Yoshida K, Hara A.

Oncotarget. 2015 Sep 22;6(28):24722-32. doi: 10.18632/oncotarget.4406.

13.

Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice.

Ohno T, Shimizu M, Shirakami Y, Miyazaki T, Ideta T, Kochi T, Kubota M, Sakai H, Tanaka T, Moriwaki H.

Hepatol Res. 2016 Mar;46(3):E201-9. doi: 10.1111/hepr.12550. Epub 2015 Jul 27.

PMID:
26147624
14.

Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.

Okada H, Honda M, Campbell JS, Takegoshi K, Sakai Y, Yamashita T, Shirasaki T, Takabatake R, Nakamura M, Tanaka T, Kaneko S.

Cancer Sci. 2015 Sep;106(9):1143-52. doi: 10.1111/cas.12730. Epub 2015 Sep 1.

15.

Myxoinflammatory Fibroblastic Sarcoma: A Radiographical, Pathological, and Immunohistochemical Report of Rare Malignancy.

Kato M, Tanaka T, Ohno T.

Case Rep Orthop. 2015;2015:620923. doi: 10.1155/2015/620923. Epub 2015 May 18.

16.

Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.

Ohno T, Shimizu M, Shirakami Y, Baba A, Kochi T, Kubota M, Tsurumi H, Tanaka T, Moriwaki H.

PLoS One. 2015 Apr 16;10(4):e0124081. doi: 10.1371/journal.pone.0124081. eCollection 2015 Apr 16.

17.

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration.

Watanabe Y, Murata T, Amakawa M, Miyake Y, Handa T, Konishi K, Matsumura Y, Tanaka T, Takeuchi K.

Eur J Pharmacol. 2015 May 5;754:179-89. doi: 10.1016/j.ejphar.2015.02.021. Epub 2015 Feb 19.

18.

Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.

Kochi T, Shimizu M, Sumi T, Kubota M, Shirakami Y, Tanaka T, Moriwaki H.

BMC Gastroenterol. 2014 Dec 17;14:212. doi: 10.1186/s12876-014-0212-z.

19.
20.

Supplemental Content

Loading ...
Support Center